Insider Trading & Ownership - Nuvectis Pharma Inc. (NVCT)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Nuvectis Pharma Inc.
Goto Prev, 0, 1, 2
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2022-06-28
Purchase		 2022-06-30
08:30 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 4,000 $11.63 $46,540 2,968,314
(Direct)		 View
2022-06-22
Purchase		 2022-06-27
08:31 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 700 $12.09 $8,462 2,964,314
(Direct)		 View
2022-05-26
Purchase		 2022-05-31
08:31 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 1,000 $15.82 $15,820 2,963,614
(Direct)		 View
2022-05-19
Purchase		 2022-05-23
08:32 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 1,200 $16.73 $20,070 2,962,614
(Direct)		 View
2022-05-20
Purchase		 2022-05-23
08:31 am		 Nuvectis Pharma Inc. NVCT Shemesh Shay
Chief Dev. & Ops. Officer		 300 $16.54 $4,962 1,241,435
(Direct)		 View
2022-05-17
Purchase		 2022-05-19
10:21 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 2,010 $19.48 $39,155 2,961,414
(Direct)		 View
2022-05-16
Purchase		 2022-05-18
08:31 am		 Nuvectis Pharma Inc. NVCT Shemesh Shay
Chief Dev. & Ops. Officer		 242 $19.44 $4,704 1,241,135
(Direct)		 View
2022-05-13
Purchase		 2022-05-17
08:30 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 1,700 $18.82 $31,990 2,959,404
(Direct)		 View
2022-05-12
Purchase		 2022-05-16
08:33 am		 Nuvectis Pharma Inc. NVCT Hoberman Kenneth
Director		 6,000 $17.4 $104,400 55,140
(Direct)		 View
2022-05-12
Purchase		 2022-05-16
08:32 am		 Nuvectis Pharma Inc. NVCT Kaplan Matthew L.
Director		 3,000 $16.88 $50,633 35,760
(Direct)		 View
2022-05-12
Purchase		 2022-05-16
08:31 am		 Nuvectis Pharma Inc. NVCT Poradosu Enrique
Chief Science & Business Off		 670 $15.33 $10,273 1,258,319
(Direct)		 View
2022-05-12
Purchase		 2022-05-13
08:30 am		 Nuvectis Pharma Inc. NVCT Shemesh Shay
Chief Dev. & Ops. Officer		 1,278 $15.85 $20,255 1,240,893
(Direct)		 View
2022-05-12
Purchase		 2022-05-13
08:30 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 12,245 $16.99 $208,047 2,957,704
(Direct)		 View
2022-03-28
Purchase		 2022-03-29
08:31 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 4,000 $7.05 $28,200 2,825,459
(Direct)		 View
2022-03-17
Purchase		 2022-03-18
08:31 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 7,000 $7.63 $53,410 2,821,459
(Direct)		 View
2022-02-14
Purchase		 2022-02-15
09:15 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO		 8,000 $5.88 $47,040 2,814,459
(Direct)		 View
2022-02-10
Purchase		 2022-02-11
09:15 am		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO		 8,500 $6.34 $53,890 2,806,459
(Direct)		 View
2022-02-04
Purchase		 2022-02-08
6:01 pm		 Nuvectis Pharma Inc. NVCT Poradosu Enrique
Chief Science & Business Off		 4,600 $3.4422 $15,834 1,197,649
(Direct)		 View
2022-02-04
Purchase		 2022-02-08
6:00 pm		 Nuvectis Pharma Inc. NVCT Shemesh Shay
Chief Development Officer		 2,946 $3.4058 $10,034 1,179,615
(Direct)		 View
2022-02-04
Purchase		 2022-02-08
1:13 pm		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO		 232,500 $4.9598 $1,153,145 2,797,959
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2022-04-01
Option Award		 2022-04-05
4:48 pm		 2023-04-01
2032-04-01		 Nuvectis Pharma Inc. NVCT Kaplan Matthew L.
Director		 15,000 $0 15,000
(Direct)		 View
2022-04-01
Option Award		 2022-04-05
4:47 pm		 2023-04-01
2032-04-01		 Nuvectis Pharma Inc. NVCT Hoberman Kenneth
Director		 15,000 $0 15,000
(Direct)		 View
2022-04-01
Option Award		 2022-04-05
4:47 pm		 2023-04-01
2032-04-01		 Nuvectis Pharma Inc. NVCT Oliviero James F III
Director		 15,000 $0 15,000
(Direct)		 View
2022-04-01
Option Award		 2022-04-05
4:46 pm		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Poradosu Enrique
Chief Science & Business Off		 60,000 $0 1,257,649
(Direct)		 View
2022-04-01
Option Award		 2022-04-05
4:46 pm		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Shemesh Shay
Chief Dev. & Ops. Officer		 60,000 $0 1,239,615
(Direct)		 View
2022-04-01
Option Award		 2022-04-05
4:46 pm		 N/A
N/A		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO
10% Owner		 120,000 $0 2,945,459
(Direct)		 View

Ownership		 2022-03-24
08:10 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Carson Michael J.
Vice President, Finance		 0 $0 27,300
(Direct)		 View

Ownership		 2022-02-08
09:24 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Ben-Or Uri
Int. Principal Financial Off.		 0 $0 25,584
(Direct)		 View

Ownership		 2022-02-08
09:21 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT BENTSUR RON
Chairman & CEO		 0 $0 2,565,459
(Direct)		 View

Ownership		 2022-02-08
08:37 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Shemesh Shay
Chief Development Officer		 0 $0 1,176,669
(Direct)		 View

Ownership		 2022-02-08
08:32 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Kaplan Matthew L.
Director		 0 $0 62,010
(Direct)		 View

Ownership		 2022-02-08
08:29 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Hoberman Kenneth
Director		 0 $0 78,390
(Direct)		 View

Ownership		 2022-02-08
08:28 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Oliviero James F III
Director		 0 $0 39,078
(Direct)		 View

Ownership		 2022-02-08
08:26 am		 N/A
N/A		 Nuvectis Pharma Inc. NVCT Poradosu Enrique
Chief Science and Business Off		 0 $0 1,193,049
(Direct)		 View
Goto Prev, 0, 1, 2